Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | peroxisome proliferator-activated receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | aryl hydrocarbon receptor | Starlite/ChEMBL | No references |
Homo sapiens | retinoid X receptor, alpha | Starlite/ChEMBL | No references |
Homo sapiens | androgen receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | ecdysteroid receptor | retinoid X receptor, alpha | 435 aa | 352 aa | 23.9 % |
Echinococcus granulosus | ecdysone induced protein 78C | peroxisome proliferator-activated receptor gamma | 477 aa | 447 aa | 28.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0062 | 0.0454 | 0.5 |
Brugia malayi | PAS domain containing protein | 0.0073 | 0.1168 | 0.1469 |
Leishmania major | hypothetical protein, conserved | 0.0062 | 0.0454 | 0.5 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0147 | 0.5794 | 0.5594 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Schistosoma mansoni | single-minded | 0.0073 | 0.1168 | 0.0747 |
Trypanosoma brucei | Fibronectin type III domain containing protein, putative | 0.0062 | 0.0454 | 0.5 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0062 | 0.0454 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.5352 | 0.8074 |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0062 | 0.0454 | 0.5 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0159 | 0.656 | 1 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 0.652 | 1 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0147 | 0.5794 | 0.8746 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0132 | 0.4875 | 0.7241 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Brugia malayi | aryl hydrocarbon receptor AHR-1 | 0.0139 | 0.5311 | 1 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 | |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0159 | 0.656 | 1 |
Onchocerca volvulus | 0.0158 | 0.652 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.5311 | 0.8008 |
Onchocerca volvulus | 0.0062 | 0.0454 | 0.0697 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Growth inhibition (functional) | = 100 % | Growth inhibition of the compound against 4th instar larvae of Spilarctia obliqua at 5 p.p.m. concentration | Starlite. | 15026059 |
IC50 (functional) | > 20 ug ml-1 | Concentration required to inhibit growth of CCRF-CEM cells in culture for 72 h to 50% of control growth | ChEMBL. | 2391684 |
IC50 (functional) | > 20 ug ml-1 | Concentration required to inhibit growth of CCRF-CEM cells in culture for 72 h to 50% of control growth | ChEMBL. | 2391684 |
Inhibition (functional) | = 6 % | Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg | ChEMBL. | 2391684 |
Inhibition (functional) | = 33 % | Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days) | ChEMBL. | 2391684 |
Potency (functional) | 1.9371 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.5119 uM | PubChem BioAssay. qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 27.306 uM | PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 34.3762 uM | PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 34.3762 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 34.6697 uM | PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
8 literature references were collected for this gene.